a blood glucose diary or urine glucose test strips and will receive a monitoring plan with recommendations on the frequency of minimal metabolic and islet autoantibody control (HbA1c, glucose). In ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk’s Ozempic (semaglutide ... as well as death due to cardiovascular disease. Type 2 diabetes (T2D) patients with CKD will ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Novo Nordisk estimates that around 40% of people with type 2 diabetes have chronic kidney disease, which affects about 37 million adults in the United States. Last year, the FDA had approved the ...

The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA ...